1. Alzheimer's disease: Neurotransmitters of the sleep-wake cycle

   Van Erum, J., Van Dam, D. & De Deyn, P. P., Oct-2019, In : Neuroscience and Biobehavioral Reviews. 105, p. 72-80 9 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?

   Van Dam, D. & De Deyn, P. P., 8-Oct-2019, In : Expert Opinion on Drug Discovery. 3 p.

   Research output: Contribution to journal › Editorial › Academic › peer-review

3. Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in mice

   Roth, L., Van der Donckt, C., Veseli, B. E., Van Dam, D., De Deyn, P. P., Martinet, W., Herman, A. G. & De Meyer, G. R. Y., Jul-2019, In : Vascular pharmacology. 118-119, 7 p., 106561.

   Research output: Contribution to journal › Article › Academic › peer-review

4. PTZ-induced seizures in mice require a revised Racine scale

   Van Erum, J., Van Dam, D. & De Deyn, P. P., Jun-2019, In : Epilepsy & Behavior. 95, p. 51-55 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Evaluating the applicability of mouse SINEs as an alternative normalization approach for RT-qPCR in brain tissue of the APP23 model for Alzheimer's disease

   Janssens, J., Crans, R. A. J., Van Craenenbroeck, K., Vandesompele, J., Stove, C. P., Van Dam, D. & De Deyn, P. P., 15-May-2019, In : Journal of Neuroscience Methods. 320, p. 128-137 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (53) »